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1120-63 Comparison of Intracoronary Bolus Injection and 
Intracoronary Continuous Infusion Methods for 
Inducing Hyperemia
Tae-Young Choi, Seung-Jea Tahk, Myeong-Ho Yoon, So-Yeon Choi, Min-Cheul Kim, 
Heung –Mo Yang, Jung-Hyun Choi, Zhen-Guo Zheng, Long Qi, Byoung-Joo Choi, Hyuk-
Jae Chang, Gyo-Seung Hwang, Joon-Han Shin, Byung-il W. Choi, Ajou University 
School of Medicine, Suwon, South Korea
Background: The method to induce coronary hyperemia with maximal and steady state
is important to evaluate microvascular circulation by coronary flow reserve(CFR) and
fraction flow reserve(FFR). We studied the method of induing hyperemia with intra-coro-
nary(IC) adenosine bolus injection and continuous infusion.
Methods: CFR was evaluated in thirty-six coronary lesions(LAD 23, LCX 5, RCA 8) in 23
patients(male 18, mean 58±12 y; SA 2, UA 12, AMI 9) and FFR was evaluated in twenty
lesions(LAD 13, LCX 6, RCA 1) in 10 patients(male 8, mean 60±11 y; SA 1, UA 7, AMI
2). To induce maximal coronary hyperemia, two methods were applied to same patient;
Method A(IC adenosine bolus injection(RCA 24µg, LCA 48µg)) and Method B(IC ade-
nosine continuous infusion(240µg/min). CFR was defined as a ratio of hyperemic(hAPV)
to baseline APV(bAPV). FFR was defined as a ratio of mean aortic pressure to mean
coronary pressure of distal part to lesion during maximal hyperemia. Hyperemic average
peak velocity(hAPV, cm/sec), CFR and FFR were compared with paired t-test in two
methods.
Results: All patients were tolerable during maximal hyperemic period. During maximal
coronary hyperemia, heart rate and mean blood pressure were not different between two
methods. Transient AV block occurred in 2 patients with method A and in 2 same patients
with method B. The duration of maintenance of hyperemia was mean 24.6±5.4 seconds
in method A and all patient except 2 patients were maintained stable hyperemia with
method B during continuous infusion of adenosine. CFR and hAPV were significantly
higher by using of method B than those of method A(3.4±2.1 vs. 2.9±1.2, p=.01 ;
52.5±23.4 vs. 45.7±19.9, p<0.01, respectively). FFR was significantly lower by using of
method B than that of A(0.76±0.17 vs. 0.80±0.15, p<0.01).
Conclusion: Compared with intracoronary adenosine bolus injection method(24-48µg),
intracoronary adenosine continuous infusion method(240µg/min) was more effective and
stable for inducing maximal hyperemia.
1120-64 High Left Ventricular Mass Does Not Limit the Utility of 
Fractional Flow Reserve for the Physiologic 
Assessment of Lesion Severity
Adnan K. Chhatriwalla, Kurt G. Barringhaus, Michael Ragosta, Eric R. Powers, J. 
Christopher McClish, Joshua Fischer, Andrew H. Bishop, Lawrence W. Gimple, Ian J. 
Sarembock, C. Joon Choi, Christopher M. Kramer, Habib Samady, The University of 
Virginia, Charlottesville, VA
Background: Fractional Flow Reserve (FFR) has been shown to be a useful invasive
physiologic index of coronary lesion severity. Increased left ventricular mass (LVM) can
impair microvascular reserve. However, whether increased LVM sufficiently impacts flow
reserve to effect clinical FFR measurements is not known.
Methods: LVM was calculated from contrast left ventriculography in 84 patients using a
modified Rackley method, which correlated well with LVM measured by cardiac MRI in 17
patients who had undergone both tests (r=0.80, p<0.001). The cohort was divided into
normal and high left ventricular mass index (LVMI) groups based on published normal
values. Cardiac risk factors and lesion FFR were compared in 22 vessels of patients with
high LVMI to 62 angiographically matched lesions in vessels of patients with normal
LVMI.
Results: LVMI was 84±21 g/m2 and 126±21 g/m2 in the normal and high LVMI groups,
respectively. There were no differences in age (59 vs 58 yrs, p=ns), presence of diabetes
(26% vs 27%, p=ns), hypertension (60% vs 73%, p=ns), dyslipidemia (56% vs 64%,
p=ns) or angiographic LVEF (58% vs 62%, p=ns) between groups. Importantly, in lesions
with similar angiographic characteristics, there was no difference in FFR between groups.
(Table). 
Conclusion: FFR of lesions in patients with high LVM is no different to FFR of angio-
graphically similar lesions in patients with normal LVM. These findings suggest that
increased LVM should not limit the utility of FFR as a physiologic index of lesion severity.
1120-65 Emboli Protection Improves Thrombolysis in Myocardial 
Infarction Perfusion Score in Saphenous Vein Graft 
Intervention
Jose E. Exaire, Cameron Haery, Deepak L. Bhatt, Sorin J. Brener, Stephen G. Ellis, Jay 
S. Yadav, Eric J. Topol, Cleveland Clinic Foundation, Cleveland, OH
Background: Use of emboli protection devices (EPD) during saphenous vein graft per-
cutaneous coronary intervention (SVG-PCI) has been proven to reduce major adverse
cardiac events (MACE) specifically the composite of myocardial infarction, urgent target
vessel revascularization, and death. However, the impact of EPD on the microcirculation
using TIMI myocardial perfusion score (TMP) has not been fully characterized. We
sought to analyze TMP in both unprotected- and EPD- SVG-PCI and its impact on 30-day
MACE.
Methods: From August 2001 to December 2002, 305 patients had a SVG-PCI suitable
for EPD; 247 (81%) had an angiogram appropriate for TMP evaluation. Of those, 49
(20%) had an EPD deployed during the coronary intervention. Both groups were similar
regarding most demographic features, but use of GP IIb/IIIa inhibitors was more frequent
in the EPD group (87% vs 74% P=0.007).
Results: TMP 3 score was obtained in 87% of the EPD group vs 56% of the unprotected
SVG-PCI (P<0.01) (Figure 1). MACE was 4.2% in the EPD group vs. 8.1% in the unpro-
tected SVG-PCI group (P=0.04). Unprotected SVG-PCI patients with TMP scores lower
than 3 had a trend towards increased total post-procedural CK (177 U/L vs 133 U/L
P=0.07), and CK-MB (21 ng/mL vs 6 ng/mL P=0.07).
Conclusions: EPD SVG-PCI improves TMP score when compared to unprotected SVG-
PCI. This finding was associated with a decrease in post-procedural MACE. 
1120-66 Early Saphenous Vein Graft Failure: A Predictor of Poor 
Outcomes After Percutaneous Coronary Intervention
Daniel Arthur Canos, Gary S. Mintz, Ben Y. Rock, Esteban Escolar, Natalie Gevorkian, 
Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Neil J. Weissman, Washington 
Hospital Center, Washington, DC
Background: While most saphenous vein grafts (SVGs) remain patent for approximately
ten years, up to 15-20% of SVGs become occluded within the first year of implantation.
The results following percutaneous coronary intervention (PCI) of early compared to late
graft failure are not well known.
Methods: We identified 100 pts (121 lesions) with early (< 1yr) SVG failure and 200 pts
(289 lesions) with late (> 1yr) SVG failure that underwent PCI. Pts were matched for
hypercholesterolemia and diabetes. Data on procedure, post-procedure coronary
angiography, and 1-year follow-up were analyzed. Angiographic measurements included
reference size, final minimum lumen diameter (MLD), lesion length, and final diameter
stenosis (DS).
Results: Early and late failure graft age was 6.0 ± 2.9 months and 105.4 ± 50.8 months
respectively. The early group had smaller references (2.78± 0.81 vs 3.30± 0.76 mm, p<
0.01), smaller final MLD (2.33 ± 0.96 vs 2.91 ± 0.85, p< 0.01), and larger final DS (16.6 ±
24% vs 11.6 ± 18.1%, p= 0.03).
Procedural success was 96% in both groups; only 1 pt in each group had an in-hospital
QMI, and 13.4% of early and 13.5% of late pts had a Non-Q MI (CKMB>5xNL). Stent use
was not related to one-year target vessel revascularization (TVR) 29.8% in the stent
group and 32.1% in the no stent group. However, the early SVG failure group had a sig-
nificantly higher rate of TVR at one-year (38.6% vs 26.6%, p= 0.04). On multivariate
analysis examining stent use, time of graft closure, and final DS; early graft closure was
the strongest predictor of TVR (p= 0.06)
Conclusion: Despite a high rate of procedural success, 1-year TVR is higher in SVGs
with early failure. Further investigation with novel interventional devices or techniques is
necessary in this high risk population to eventually improve long term outcomes. 
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1121-47 Bone Marrow and Neural Crest Derived Cells Contribute 
to In-Stent Restenosis
Gerhard Bauriedel, Dirk Skowasch, Alexander Jabs, René Andrié, Berndt Lüderitz, Heart 
Center University of Bonn, Bonn, Germany
Objective: In in-stent restenosis (ISR), a significant number of intimal mesenchymal
cells remain unidentified. Also, there is ongoing controversy on the origin of neointimal
cells. Therefore, the objective of the present study was to assess cellularity, cell type and
origin of neointimal cells.
Reference 
Diameter 
(mm)
Minimum 
Luminal 
Diameter (mm)
Percent 
Diameter 
Stenosis (%)
Lesion 
length(m
m)
FFR
High 
LVMI(n=22)
3.3±0.5 1.3±0.6 61±13 14.2±7 0.79±0.12
Normal 
LVMI(n=62)
3.1±0.7 1.3±0.6 62±13 14.3±7 0.78±0.16
p-value ns ns ns ns ns
